Author: Andelyn Biosciences

Posted Date:

April 14, 2026

Andelyn Biosciences Partners with Evolyra Therapeutics for the Clinical Manufacturing of Gene Therapies for the Treatment of Limb-Girdle Muscular Dystrophies

Andelyn Biosciences

April 14, 2026
Andelyn Biosciences Establishes The Andelyn Foundation to Support Families Living with Rare and Ultra-Rare Diseases

Andelyn Biosciences

March 10, 2026
Andelyn Biosciences to Apply the AAV Curator® Platform to Manufacture Clinical Grade AAV for Drake Rayden Foundation for the Treatment of Nonketotic Hyperglycinemia

Andelyn Biosciences

February 17, 2026